Feedback (FDBK) Competitors

Feedback logo
GBX 3.80 -0.05 (-1.30%)
As of 11/17/2026 12:42 PM Eastern

FDBK vs. IQAI, DVRG, SENS, TRLS, and EMIS

Should you buy Feedback stock or one of its competitors? Feedback's main competitors and comparable companies include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), Trellus Health (TRLS), and EMIS Group (EMIS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Feedback compare to IQ-AI?

Feedback (LON:FDBK) and IQ-AI (LON:IQAI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the broader market.

IQ-AI has lower revenue, but higher earnings than Feedback.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K1.96-£10.84M-£15.74N/A
IQ-AI£538.19K3.30N/AN/AN/A

In the previous week, Feedback's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
IQ-AI Neutral

31.5% of Feedback shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Comparatively, 66.0% of IQ-AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

IQ-AI has a net margin of -77.52% compared to Feedback's net margin of -446.94%. Feedback's return on equity of -96.66% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-446.94% -96.66% -22.99%
IQ-AI -77.52%-140.75%-22.03%

Summary

IQ-AI beats Feedback on 5 of the 9 factors compared between the two stocks.

How does Feedback compare to DeepVerge?

DeepVerge (LON:DVRG) and Feedback (LON:FDBK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

DeepVerge has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, Feedback has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

DeepVerge has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DeepVerge£12.41M0.00-£2.46M-£0.01N/A
Feedback£849.62K1.96-£10.84M-£15.74N/A

In the previous week, DeepVerge's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
DeepVerge Neutral
Feedback Neutral

DeepVerge has a net margin of -19.81% compared to Feedback's net margin of -446.94%. DeepVerge's return on equity of -10.27% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
DeepVerge-19.81% -10.27% -5.56%
Feedback -446.94%-96.66%-22.99%

4.2% of DeepVerge shares are owned by institutional investors. Comparatively, 31.5% of Feedback shares are owned by institutional investors. 9.5% of DeepVerge shares are owned by company insiders. Comparatively, 8.0% of Feedback shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

DeepVerge beats Feedback on 8 of the 10 factors compared between the two stocks.

How does Feedback compare to Sensyne Health?

Feedback (LON:FDBK) and Sensyne Health (LON:SENS) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

31.5% of Feedback shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Feedback's average media sentiment score of 0.00 equaled Sensyne Health'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Sensyne Health Neutral

Sensyne Health has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K1.96-£10.84M-£15.74N/A
Sensyne Health£7.81M0.00N/A-£22.10N/A

Sensyne Health has a net margin of 0.00% compared to Feedback's net margin of -446.94%. Sensyne Health's return on equity of 0.00% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-446.94% -96.66% -22.99%
Sensyne Health N/A N/A N/A

Summary

Sensyne Health beats Feedback on 5 of the 8 factors compared between the two stocks.

How does Feedback compare to Trellus Health?

Trellus Health (LON:TRLS) and Feedback (LON:FDBK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Feedback Neutral

Feedback has a net margin of -446.94% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-6,826.32% -49.78% -22.76%
Feedback -446.94%-96.66%-22.99%

Trellus Health has a beta of 2.509, meaning that its share price is 151% more volatile than the broader market. Comparatively, Feedback has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 31.5% of Feedback shares are held by institutional investors. 9.6% of Trellus Health shares are held by company insiders. Comparatively, 8.0% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Trellus Health has higher earnings, but lower revenue than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Feedback£849.62K1.96-£10.84M-£15.74N/A

Summary

Trellus Health beats Feedback on 7 of the 11 factors compared between the two stocks.

How does Feedback compare to EMIS Group?

EMIS Group (LON:EMIS) and Feedback (LON:FDBK) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

EMIS Group has a net margin of 17.23% compared to Feedback's net margin of -446.94%. EMIS Group's return on equity of 23.17% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
EMIS Group17.23% 23.17% 7.99%
Feedback -446.94%-96.66%-22.99%

105.6% of EMIS Group shares are held by institutional investors. Comparatively, 31.5% of Feedback shares are held by institutional investors. 3.6% of EMIS Group shares are held by insiders. Comparatively, 8.0% of Feedback shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

EMIS Group has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EMIS Group£176.86M0.00£30.48M£0.47N/A
Feedback£849.62K1.96-£10.84M-£15.74N/A

EMIS Group has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market. Comparatively, Feedback has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market.

In the previous week, EMIS Group's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
EMIS Group Neutral
Feedback Neutral

Summary

EMIS Group beats Feedback on 8 of the 10 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FDBK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealthcare Technology IndustryHealthcare SectorLON Exchange
Market Cap£1.67M£1.97B£7.83B£2.79B
Dividend Yield4.56%3.89%2.47%5.11%
P/E Ratio-0.2438.5133.0223.17
Price / Sales1.965.578.565.10
Price / Cash1.1215.6721.0120.23
Price / Book0.074.704.462.48
Net Income-£10.84M-£19.09M£3.52B£5.88B
7 Day Performance4.83%-7.84%-5.94%-1.44%
1 Month Performance-40.44%-5.72%-4.59%-2.86%
1 Year Performance-56.32%-11.40%-1.94%7.76%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 3.80
-1.3%
N/A-56.3%£1.67M£849.62KN/A24
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70
TRLS
Trellus Health
N/AGBX 0.12
flat
N/AN/A£516K£359KN/A31

Related Companies and Tools


This page (LON:FDBK) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners